A cognitive therapy conceptualization of panic disorder exacerbated by interferon treatment

被引：6

作者：

Farber, GA ^{[1
]}

Levin, T

White, CA

机构：

[1] Long Isl Jewish Med Ctr, Dept Consultat & Liaison Psychiat, New Hyde Pk, NY 11040 USA

[2] Ayrshire Cent Hosp, Consulting & Clin Psychol Serv, NHS Ayrshire & Arran, Irvine KA12 8SS, Scotland

[3] Univ Glasgow, Fac Med, Glasgow G12 0XH, Lanark, Scotland

来源：

GENERAL HOSPITAL PSYCHIATRY | 2005年 / 27卷 / 05期

关键词：

panic disorder; anxiety; interferon; hepatitis C; cognitive therapy;

D O I：

10.1016/j.genhosppsych.2005.05.012

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

This case conference presents a patient with von Willebrand disease, receiving year-long interferon treatment for hepatitis C. She was referred to C-L Psychiatry following a severe exacerbation of panic disorder. Our guest interviewer is Dr. Craig White, a Scottish cognitive therapist. The subsequent discussion outlines the treatment challenges of panic disorder that occurs when a patient is receiving interferon. A literature review evaluates psychological effects of interferon and biological mechanisms by which interferon may exacerbate anxiety and depression. A cognitive therapy conceptualization of interferon-induced exacerbation of panic disorder is proposed. (c) 2005 Elsevier Inc. All rights reserved.

引用

页码：329 / 337

页数：9

共 30 条

[1]

ALTER MJ, 1997, HEPATOLOGY S1, V26, P62

[2] AN INVENTORY FOR MEASURING CLINICAL ANXIETY - PSYCHOMETRIC PROPERTIES [J].

BECK, AT ;

BROWN, G ;

EPSTEIN, N ;

STEER, RA .

JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1988, 56 (06) :893-897

[3]

BECK AT, 1992, AM J PSYCHIAT, V149, P778

[4] PSYCHOMETRIC PROPERTIES OF THE BECK DEPRESSION INVENTORY - 25 YEARS OF EVALUATION [J].

BECK, AT ;

STEER, RA ;

GARBIN, MG .

CLINICAL PSYCHOLOGY REVIEW, 1988, 8 (01) :77-100

[5]

BLACK DW, 1993, ARCH GEN PSYCHIAT, V50, P44

[6] Increased depressive ratings in patients with hepatitis C receiving interferon-α-based immunotherapy are related to interferon-α-induced changes in the serotonergic system [J].

Bonaccorso, S ;

Marino, V ;

Puzella, A ;

Pasquini, M ;

Biondi, M ;

Artini, M ;

Almerighi, C ;

Verkerk, R ;

Meltzer, H ;

Maes, M .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (01) :86-90

[7] Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms [J].

Bonaccorso, S ;

Puzella, A ;

Marino, V ;

Pasquini, M ;

Biondi, M ;

Artini, M ;

Almerighi, C ;

Levrero, M ;

Egyed, B ;

Bosmans, E ;

Meltzer, HY ;

Maes, M .

PSYCHIATRY RESEARCH, 2001, 105 (1-2) :45-55

[8]

Butler AC, 2000, J NORWEGIAN PSYCHOL, V37, P1

[9] Interferon-alpha-induced changes in tryptophan metabolism: Relationship to depression and paroxetine treatment [J].

Capuron, L ;

Neurauter, G ;

Musselman, DL ;

Lawson, DH ;

Nemeroff, CB ;

Fuchs, D ;

Miller, AH .

BIOLOGICAL PSYCHIATRY, 2003, 54 (09) :906-914

[10] A COGNITIVE APPROACH TO PANIC [J].

CLARK, DM .

BEHAVIOUR RESEARCH AND THERAPY, 1986, 24 (04) :461-470

← 1 2 3 →